Neuroprotection targeting protein misfolding on chronic cerebral hypoperfusion in the context of metabolic syndrome

Mostrar todas las versiones(2)

Abstract: Metabolic syndrome (MetS) is a cluster of risk factors that lead to microvasculardysfunction and chronic cerebral hypoperfusion (CCH). Long-standing reduction inoxygen and energy supply leads to brain hypoxia and protein misfolding, thereby linkingCCH to Alzheimer’s disease. Protein misfol...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Herrera, María Inés, Udovin, Lucas Daniel, Toro-Urrego, Nicolás, Kusnier, Carlos Federico, Luaces, Juan P., Otero Losada, Matilde, Capani, Francisco
Formato:	Artículo
Lenguaje:	Inglés
Publicado:	Frontiers Media 2019
Materias:	SINDROME METABOLICO CEREBRO PROTEINAS ENFERMEDADES NEURODEGENERATIVAS
Acceso en línea:	https://repositorio.uca.edu.ar/handle/123456789/6169
Aporte de:	Repositorio Institucional de la Universidad Católica Argentina (UCA) de Universidad Católica Argentina

Ejemplares similares

Neuroprotection targeting protein misfolding on chronic cerebral hypoperfusion in the context of metabolic syndrome
por: Herrera, María I., et al.
Publicado: (2019)

Neuroprotection from protein misfolding in cerebral hypoperfusion concurrent with metabolic syndrome: a translational perspective
por: Bordet, Sofía, et al.
Publicado: (2023)

Neuroprotection in metabolic syndrome by environmental enrichment: a lifespan perspective
por: Kobiec, Tamara, et al.
Publicado: (2023)

Link Between Metabolic Syndrome and Brain Health
por: Diaz-Gerevini, Gustavo, et al.
Publicado: (2023)

Neuroprotective properties of cannabinoids in cellular and animal models : hypotheses and facts
por: Udovin, Lucas Daniel, et al.
Publicado: (2021)

Melatonin, mitochondria, and the metabolic syndrome
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

Cytoprotection by melatonin: The metabolic syndrome as an example
por: Cardinali, Daniel Pedro, et al.
Publicado: (2022)

Melatonin and the metabolic syndrome : physiopathologic and therapeutical implications
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

The polycystic ovary syndrome and the metabolic syndrome : a possible chronobiotic-cytoprotective adjuvant therapy
por: Spinedi, Eduardo J., et al.
Publicado: (2019)

A preliminary study of low-dose angiotensin 1-7 plus the pineal hormone melatonin in the treatment of human systemic diseases other than cancer and autoimmune pathologies
por: Lissoni, Paolo, et al.
Publicado: (2022)

Melatonin may curtail the metabolic syndrome : studies on initial and fully established fructose-induced metabolic syndrome in rats
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

The Metabolic syndrome and metabolic characteristics in blood donors
por: Aro, Pedro, et al.
Publicado: (2024)

Metabolic syndrome in older adults: a poblational study
por: Díaz-Gerevini, GT, et al.
Publicado: (2023)

Impact of metabolic syndrome on murine fetal programming
por: Gerbaldo, V, et al.
Publicado: (2019)

Comparison of glycemic control in diabetic patients with and without metabolic syndrome
por: Cruz del Castillo, Aaron Humberto, et al.
Publicado: (2013)

METABOLIC SYNDROME AND OBESITY ACCORDING TO IFD/LAAD CRITERIA IN ADULTS IN THE CITY OF SALTA
por: Gotthelf, Susana Judith, et al.
Publicado: (2018)

Aortic morphological changes in Metabolic Syndrome: Therapeutic contrast with atorvastatin and sleeve gastrectomy
por: Rossi, MM, et al.
Publicado: (2022)

Inflammaging, metabolic syndrome and melatonin : a call for treatment studies
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

Impact of metabolic syndrome on testicular redox status: role of an antioxidant
por: Cuevas Ibarra, AM, et al.
Publicado: (2022)

Quercetin attenuates testicular oxidative stress associated with Metabolic Syndrome
por: Rivoira, MA, et al.
Publicado: (2021)

Metabolic syndrome prevalence and clinical features in blood donors
por: Cruz del Castillo, Aaron H., et al.
Publicado: (2012)

Pharmacological analysis of metabolic syndrome appraised by oxidative stress markers
por: Castillo, TA, et al.
Publicado: (2019)

Systematic review and meta-analysis on the relationship between prenatal stress and metabolic syndrome intermediate phenotypes
por: Burgueño, Adriana, et al.
Publicado: (2020)

Systematic review and meta-analysis on the relationship between prenatal stress and metabolic syndrome intermediate phenotypes
por: Burgueño, Adriana Laura, et al.
Publicado: (2020)

Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression : an exploratory study in the PPMI database
por: Udovin, Lucas Daniel, et al.
Publicado: (2021)

Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression : an exploratory study in the PPMI database
por: Udovin, Lucas Daniel, et al.
Publicado: (2021)

The renin–angiotensin system modulates dopaminergic neurotransmission : A new player on the scene
por: Kobiec, Tamara, et al.
Publicado: (2021)

Impact of metabolic syndrome in patients with psoriatic arthritis in a cohort from the province of Córdoba
por: Figueroa, RM, et al.
Publicado: (2023)

Melatonin and diet-induced metabolic syndrome in rats. Impact on the hypophysial-testicular axis
por: Scacchi Bernasconi, Pablo A., et al.
Publicado: (2019)

Food fiber consumption antioxidant dietary ability and metabolic syndrome components.
por: Ledesma, GN, et al.
Publicado: (2019)

Metabolic syndrome in dams and fetal programming: a study in a murine model
por: Luque, EM, et al.
Publicado: (2022)

Quercetin reverses testicular damage caused by an increase in nitric oxide in an experimental model of Metabolic Syndrome.
por: Luciani, N, et al.
Publicado: (2023)

El aporte de la telemedicina en la prevención y en el tratamiento de las enfermedades neurodegenerativas.
por: Lareng, Louis

Neurodegeneraci�on y Alzh�eimer : avances tecnol�ogicos y de investigaci�on para la prevenci�on y el tratamiento /
por: Navarro Cuartiellas, Arcadi
Publicado: (2024)

Genetics of neurogenic orthostatic hypotension in Parkinson’s disease, results from a cross-sectional in silico study
por: Chevalier, Guenson, et al.
Publicado: (2023)

On the diagnosis of pain in Parkinson disease : a mechanism-based approach
por: Mylius, Veit, et al.
Publicado: (2023)

Metodología desarrollada para mejorar la calidad de vida de las personas con enfermedad de Parkinson (EP) mediante la aplicación de los principios teóricos del fenómeno paradojal en el Taller de Parkinson (TDP)
por: Dillon, José Luis, et al.
Publicado: (2010)

Neuroprotection in hypoxic-ischemic brain injury targeting glial cells
por: Herrera, María Inés, et al.
Publicado: (2022)

Metabolic engineering : principles and methodologies /
por: Stephanopoulos, G.
Publicado: (1998)

The genetic basis of probable rem sleep behavior disorder in Parkinson’s disease
por: Pérez Lloret, Santiago, et al.
Publicado: (2023)